Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.

Saved in:
Bibliographic Details
Title: Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.
Authors: Kaburaki S; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan., Tanaka T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan., Kamio K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan., Tanaka Y; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan., Kasahara K; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan., Terasaki Y; Department of Analytic Human Pathology, Nippon Medical School, Japan., Seike M; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan.
Source: Internal medicine (Tokyo, Japan) [Intern Med] 2026 Jun 01; Vol. 65 (11), pp. 1514-1519. Date of Electronic Publication: 2025 Oct 16.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1349-7235
DOI:10.2169/internalmedicine.6290-25